Prostate Cancer
The proportion of potential candidates for focal therapy in localized prostate cancer in a real-life cohort and their final pathologic results.
August 12, 2022
Final analysis of the Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial.
August 12, 2022
Race and prostate cancer: genomic landscape.
August 12, 2022
Biochemical relapse predictive factors in patients with lymph node metastases during radical prostatectomy.
August 11, 2022
Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomy.
August 10, 2022
ACCURATE PREDICTION OF LONG-TERM RISK OF BIOCHEMICAL FAILURE AFTER SALVAGE RADIOTHERAPY INCLUDING THE IMPACT OF PELVIC NODE IRRADIATION.
August 10, 2022
Avenda Health Receives FDA Investigational Device Exemption for AI-enabled Prostate Cancer Therapy
August 9, 2022